Publicaciones en las que colabora con JUAN JOSE ZARRANZ IMIRIZALDU (41)

2016

  1. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson’s disease

    Journal of Neurology, Vol. 263, Núm. 5, pp. 895-905

  2. Síntomas no motores y motores en la enfermedad de Parkinson y su relación con la calidad de vida y los distintos subgrupos clínicos

    Neurologia, Vol. 31, Núm. 9, pp. 585-591

2015

  1. Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations

    Parkinsonism and Related Disorders, Vol. 21, Núm. 7, pp. 717-722

  2. Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension

    Journal of Human Hypertension, Vol. 29, Núm. 10, pp. 604-609

  3. Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene

    Parkinsonism and Related Disorders, Vol. 21, Núm. 5, pp. 494-499

2014

  1. Impulse control and repetitive behaviors in Parkinson's disease - Are there differences in the relation to dopamine agonist treatment?

    Journal of the Neurological Sciences

2013

  1. Autonomic dysfunction in parkinsonian LRRK2 mutation carriers

    Parkinsonism and Related Disorders, Vol. 19, Núm. 10, pp. 906-909

  2. Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the α synuclein gene

    Parkinsonism and Related Disorders, Vol. 19, Núm. 1, pp. 95-100

  3. Nocturnal hypertension and dysautonomia in patients with Parkinson's disease: Are they related?

    Journal of Neurology, Vol. 260, Núm. 7, pp. 1752-1756

  4. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease

    Clinical Neurology and Neurosurgery, Vol. 115, Núm. 8, pp. 1230-1233

2012

  1. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy

    Parkinsonism and Related Disorders, Vol. 18, Núm. 1, pp. 45-48

2011

  1. Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease

    Journal of Neurology, Vol. 258, Núm. 3, pp. 494-499

  2. Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1)

    Journal of the Neurological Sciences, Vol. 310, Núm. 1-2, pp. 86-89

  3. Relationship between sleep and dysautonomic symptoms assessed by self-report scales

    Movement Disorders

2010

  1. Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the α-synuclein gene (SNCA)

    Clinical Autonomic Research, Vol. 20, Núm. 4, pp. 267-269

  2. Factors influencing the symmetry of Parkinson's disease symptoms

    Clinical Neurology and Neurosurgery, Vol. 112, Núm. 4, pp. 302-305

2009

  1. Application of depression criteria (DSM-IV) in patients with Parkinson's disease

    Clinical Neurology and Neurosurgery, Vol. 111, Núm. 8, pp. 665-669

  2. Lrrk2 R1441G-related Parkinson's disease: Evidence of a common founding event in the seventh century in Northern Spain

    Neurogenetics, Vol. 10, Núm. 4, pp. 347-353

2008

  1. Fluctuaciones motoras y discinesias en la enfermedad de Parkinson: Variables que discriminan ambas complicaciones en una muestra de 285 pacientes

    Neurologia, Vol. 23, Núm. 8, pp. 494-498

  2. Outcome of bilateral deep brain subthalamic stimulation in patients carrying the R1441G mutation in the LRRK2 dardarin gene

    Neurosurgery, Vol. 62, Núm. 4, pp. 857-862